126 related articles for article (PubMed ID: 12944056)
1. Might losartan reduce sudden cardiac death in diabetic patients with hypertension?
Aronow WS
Lancet; 2003 Aug; 362(9384):591-2. PubMed ID: 12944056
[No Abstract] [Full Text] [Related]
2. LIFE: losartan versus atenolol.
Chong AY; Lip GY
Lancet; 2003 Oct; 362(9393):1416. PubMed ID: 14585648
[No Abstract] [Full Text] [Related]
3. LIFE: losartan versus atenolol.
Ong HT
Lancet; 2003 Oct; 362(9393):1416. PubMed ID: 14585647
[No Abstract] [Full Text] [Related]
4. Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
Lindholm LH; Dahlöf B; Edelman JM; Ibsen H; Borch-Johnsen K; Olsen MH; Snapinn S; Wachtell K;
Lancet; 2003 Aug; 362(9384):619-20. PubMed ID: 12944063
[TBL] [Abstract][Full Text] [Related]
5. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
[TBL] [Abstract][Full Text] [Related]
6. The LIFE Trial in 2004.
Beevers DG
J Hum Hypertens; 2004 Jun; 18(6):365. PubMed ID: 15153931
[No Abstract] [Full Text] [Related]
7. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
[No Abstract] [Full Text] [Related]
8. [When compliance doesn't work out. Calculate the risk of stroke for hypertensive patients!].
MMW Fortschr Med; 2004 Feb; 146(7):61. PubMed ID: 15347060
[No Abstract] [Full Text] [Related]
9. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
[No Abstract] [Full Text] [Related]
10. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Fuchs FD
Lancet; 2002 Jun; 359(9324):2203; author reply 2203-4. PubMed ID: 12091010
[No Abstract] [Full Text] [Related]
11. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
Traut
Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
[No Abstract] [Full Text] [Related]
12. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
[No Abstract] [Full Text] [Related]
13. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
Dominiak P; Zidek W
MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
[No Abstract] [Full Text] [Related]
14. [What are the consequences of the LIFE Study for general practice].
Zidek W
MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
[No Abstract] [Full Text] [Related]
15. [Results from the LIFE study: promising effects of new hypertensive agents].
Nilsson P; Kahan T
Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477
[No Abstract] [Full Text] [Related]
16. Effects of losartan in hypertension without vascular disease.
Messerli FH
Ann Intern Med; 2004 Apr; 140(7):W29. PubMed ID: 15069010
[No Abstract] [Full Text] [Related]
17. Pulse pressure and antihypertensive agents.
Safar ME; O'Rourke MF
Hypertension; 2005 Aug; 46(2):e6; author reply e6-7. PubMed ID: 16027242
[No Abstract] [Full Text] [Related]
18. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
[TBL] [Abstract][Full Text] [Related]
19. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Baumgart P
MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
